Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.91 USD | +19.75% | +6.96% | -60.27% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-60.27% | 71.16M | |
+9.37% | 45.97B | |
+52.73% | 43.93B | |
+7.38% | 42.34B | |
-8.78% | 28.27B | |
+17.95% | 27.18B | |
-21.23% | 19.44B | |
+14.47% | 13.83B | |
+31.95% | 12.4B | |
+5.32% | 11.45B |
- Stock
- Equities
- Stock Immuneering Corporation - Nasdaq
- News Immuneering Corporation
- Immuneering Files Investigational New Drug Application With FDA for Solid Tumor Trial of IMM-1-104